OTC Markets OTCPK - Delayed Quote USD

Range Impact, Inc. (RNGE)

Compare
0.2300 -0.0300 (-11.54%)
At close: 2:59 PM EDT
Loading Chart for RNGE
DELL
  • Previous Close 0.2600
  • Open 0.2230
  • Bid 0.2300 x --
  • Ask 0.2761 x --
  • Day's Range 0.2230 - 0.2300
  • 52 Week Range 0.1000 - 0.5500
  • Volume 9,972
  • Avg. Volume 30,621
  • Market Cap (intraday) 24.087M
  • Beta (5Y Monthly) 2.05
  • PE Ratio (TTM) 11.50
  • EPS (TTM) 0.0200
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Range Impact, Inc., together with its subsidiaries, provides health and wellness products in the United States. The company operates through five segments: Range Reclaim, Range Water, Range Security, Range Land, and Drug Development. It develops VBX-100, a glycosylated tetrahydrocannabinol cannabinoid for the inflammatory conditions of the gastrointestinal tract. It also offers land reclamation, water restoration, and incidental mining services to mining and non-mining companies throughout Appalachia; and environmental security services, such as technology-driven security services to active and former mine sites. The company was formerly known as Malachite Innovations, Inc. and changed its name to Range Impact, Inc. in December 2023. Range Impact, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.

www.rangeimpact.com

44

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RNGE

View More

Performance Overview: RNGE

Trailing total returns as of 10/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RNGE
14.81%
S&P 500
19.42%

1-Year Return

RNGE
27.78%
S&P 500
32.20%

3-Year Return

RNGE
25.81%
S&P 500
30.53%

5-Year Return

RNGE
91.67%
S&P 500
92.95%

Compare To: RNGE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RNGE

View More

Valuation Measures

Annual
As of 10/4/2024
  • Market Cap

    27.23M

  • Enterprise Value

    36.12M

  • Trailing P/E

    11.61

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.32

  • Price/Book (mrq)

    3.33

  • Enterprise Value/Revenue

    1.94

  • Enterprise Value/EBITDA

    8.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.74%

  • Return on Assets (ttm)

    -0.96%

  • Return on Equity (ttm)

    15.49%

  • Revenue (ttm)

    18.59M

  • Net Income Avi to Common (ttm)

    881.63k

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    123.71k

  • Total Debt/Equity (mrq)

    110.17%

  • Levered Free Cash Flow (ttm)

    -778.98k

Research Analysis: RNGE

View More

Revenue vs. Earnings

Revenue 2.35M
Earnings -1.23M
 

Analyst Price Targets

 

Company Insights: RNGE

People Also Watch